UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	December 9, 2024

Accession Number:	0001104659-24-123690
Submission Type:	POS AM
CIK: 0000827871 Company Name: EAGLE PHARMACEUTICALS, INC. File Number: 333-202592